Virginia’s bioscience industry continues robust growth, supported by over $1 billion in R&D and 415 new patents in 2023. The Biotechnology Innovation Organization (BIO) captured this momentum during its July visit, engaging local leaders and touring key facilities, including Phlow—a BARDA-backed site focused on domestic small-molecule active pharmaceutical ingredient manufacturing. Virginia’s bioscience businesses employ over 30,000 people statewide. The state’s strategic investments aim to bolster pharmaceutical supply chain resilience and biotech innovation, fostering a business-friendly environment that ranks fourth nationally.